UPDATE: Immunic Inc. (IMUX) Announces Positive Top-Line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting MS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. ACN
4. IONS
5. AZN
6. ROIV
7. AAPL
8. NVDA
9. USO
10. ORCL

Go back to UPDATE: Immunic Inc. (IMUX) Announces Positive Top-Line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting MS
(NASDAQ: IMUX) Delayed: 13.10 -0.01 (0.08%)
Previous Close $13.11    52 Week High $ 
Open $12.93    52 Week Low $ 
Day High $13.28    P/E N/A 
Day Low $12.35    EPS $ 
Volume 222,982